Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,403.05
(
-0.07%
)
US TECH 100
28,271.20
(
-0.30%
)
Dow Jones
49,686.12
(
0.32%
)
Brent Oil
106.60
(
-0.15%
)
Bitcoin
76,608.11
(
-0.47%
)
News Focus
News Focus
Post# of 257581
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122989
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jq1234 post# 173329

Tuesday, 01/28/2014 7:11:40 PM

Tuesday, January 28, 2014 7:11:40 PM

Post# of 257581
There are several entries in the MNTA ReadMeFirst (#msg-96385440) devoted to Teva’s thrice-weekly Copaxone, so I have nothing to say about it here except to re-iterate that the new thrice-weekly drug is not directly substitutable for regular (daily) Copaxone.

(The latest version of the MNTA ReadMeFirst can always be accessed from the red button on the main screen of this message board.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today